COMI, MICHELA
COMI, MICHELA
Mostra
prodotti
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.007 secondi).
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era. A single center, observational study
2024 Oliva, Alessandra; Liguori, L; Covino, S; Petrucci, F; Cogliati-Dezza, F; Curtolo, A; Savelloni, G; Comi, M; Sacco, F; Ceccarelli, G; Viscido, A; Alessandri, F; Raponi, G; Pugliese, F; Mastroianni, C M; Venditti, M
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study
2024 Oliva, Alessandra; Liguori, L; Covino, S; Petrucci, F; Cogliati-Dezza, F; Curtolo, A; Savelloni, G; Comi, M; Sacco, F; Ceccarelli, G; Viscido, A; Alessandri, F; Raponi, G; Pugliese, F; Mastroianni, Cm; Venditti, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era. A single center, observational study | 2024 | Oliva, Alessandra; Liguori, L; Covino, S; Petrucci, F; Cogliati-Dezza, F; Curtolo, A; Savelloni, G; Comi, M; Sacco, F; Ceccarelli, G; Viscido, A; Alessandri, F; Raponi, G; Pugliese, F; Mastroianni, C M; Venditti, M | |
| Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study | 2024 | Oliva, Alessandra; Liguori, L; Covino, S; Petrucci, F; Cogliati-Dezza, F; Curtolo, A; Savelloni, G; Comi, M; Sacco, F; Ceccarelli, G; Viscido, A; Alessandri, F; Raponi, G; Pugliese, F; Mastroianni, Cm; Venditti, M |